Cargando…
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases
In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against CO...
Autores principales: | Furer, Victoria, Rondaan, Christien, Agmon-Levin, Nancy, van Assen, Sander, Bijl, Marc, Kapetanovic, Meliha Crnkic, de Thurah, Annette, Mueller-Ladner, Ulf, Paran, Daphna, Schreiber, Karen, Warnatz, Klaus, Wulffraat, Nico M, Elkayam, Ori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907831/ https://www.ncbi.nlm.nih.gov/pubmed/33627440 http://dx.doi.org/10.1136/rmdopen-2021-001594 |
Ejemplares similares
-
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
por: Rondaan, Christien, et al.
Publicado: (2019) -
Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD
por: Furer, Victoria, et al.
Publicado: (2019) -
Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entities
por: Cappelli, Laura C, et al.
Publicado: (2016) -
Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity
por: Calabrese, C, et al.
Publicado: (2017) -
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
por: Burska, Agata, et al.
Publicado: (2023)